Emyria Limited (EMD) - Share Price and Research

$0.080 0.003 (3.61%)

EMD General Information +

GICS Sub-Industry Health Care Facilities
Market Cap ($M) 8
EMD Share Price $0.080
Day High $0.082
Day Low $0.077
Last Close $0.083
EMD Share Price Movement $0.00 ( 3.61% )
Prices as at 16:40, 25 Sep 2020
+Security prices are delayed by at least 20 minutes and are indicative only.

EMD Company Overview

Business Description

Emyria Limited (EMD, formerly Emerald Clinics Limited) operates a Real-World Evidence using its network of specialist medical clinics and purpose-built, remote patient monitoring software and technology to gather high quality clinical data from informed and consenting patients. EMD's model provides a clinical services and healthcare technology that focused on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines.

EMD Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2020 A -5.20 -3.00 0.00% 0.00 0.00 0.00% 0.0%
2019 A 0.00 0.00 0.00% 0.00 0.00 0.00% 0.0%

EMD Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 3.88 0.00
Market 0.54 18.20 1.52 1.26
Sector 0.96 27.20 3.37 3.58

EMD Directors

Name Position Start Date
Dr Stewart James Washer Executive Chairman, Executive Director 19 Mar 2018
Dr Alistair Vickery Executive Director 2 Nov 2018
Dr Michael Winlo Managing Director 8 Nov 2019
Mr Matthew (Matt) Callahan Non-Executive Director 19 Mar 2018
Sir John Tooke Non-Executive Director 10 Feb 2020

EMD Management

Name Position
Su-Mei Sain Chief Financial Officer
Adam James Chief Operating Officer
Simon Lee Robertson Company Secretary

EMD Substantial Shareholders

Holding Name
0 (0%) No substantial shareholder's information disclosed

EMD Calendar of Events

Date Event
30 August 2021 Report (Prelim)
26 February 2021 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.